Cargando…

Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia

BACKGROUND: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease characterized by an elevation in the serum levels of total cholesterol and of low-density lipoproteins (LDL- c). Known to be closely related to the atherosclerotic process, FH can determine the development of ear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Carolina, Miname, Marcio, Makdisse, Marcia, Kalil, Roberto, Santos, Raul D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150662/ https://www.ncbi.nlm.nih.gov/pubmed/25029472 http://dx.doi.org/10.5935/abc.20140097

Ejemplares similares

Healthy Lifestyles and Cardiovascular Disease in Familial Hypercholesterolemia: Can We Change the Impact of Genes?
por: Santos, Raul D.
Publicado: (2023)

New Trends and Therapies for Familial Hypercholesterolemia
por: Alnouri, Fahad, et al.
Publicado: (2022)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Phytosterols in the Treatment of Hypercholesterolemia and Prevention of Cardiovascular Diseases
por: Cabral, Carlos Eduardo, et al.
Publicado: (2017)

Past, Present, and Future of Familial Hypercholesterolemia Management
por: Rocha, Viviane Z., et al.
Publicado: (2021)

Fatty Acid and Cholesterol Concentrations in Usually Consumed Fish in Brazil
por: Scherr, Carlos, et al.
Publicado: (2015)

What Arteries are Affected in Familial Hypercholesterolemia?
por: Harada-Shiba, Mariko
Publicado: (2019)

Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system
por: Bahia, Luciana R., et al.
Publicado: (2018)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge
por: Vuorio, Alpo, et al.
Publicado: (2021)

Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
por: Boutari, Chrysoula, et al.
Publicado: (2022)

Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia
por: Michikura, Masahito, et al.
Publicado: (2022)

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
por: Watanabe, Jun, et al.
Publicado: (2020)

Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia
por: Silva, Pãmela Rodrigues de Souza, et al.
Publicado: (2018)

Familial Hypercholesterolemia and the Atherosclerotic Disease
por: Kim, Yoo Ri, et al.
Publicado: (2013)

Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease
por: Katamine, Masahiro, et al.
Publicado: (2021)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Association of triglyceride-glucose index with atherosclerotic cardiovascular disease and mortality among familial hypercholesterolemia patients
por: Wen, Jun, et al.
Publicado: (2023)

The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia
por: Kovács, Beáta, et al.
Publicado: (2022)

The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia
por: Korneva, Victoria, et al.
Publicado: (2022)

Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia
por: Ravnskov, Uffe, et al.
Publicado: (2022)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia
por: Santos, Paulo C.J.L., et al.
Publicado: (2014)

Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
por: Lee, Sang-Hak
Publicado: (2017)

Identifying Markers of Cardiovascular Event-Free Survival in Familial Hypercholesterolemia
por: Khoury, Etienne, et al.
Publicado: (2020)

Early echocardiographic signs of cardiovascular affection in pediatric familial hypercholesterolemia
por: Ibrahim, Hossam, et al.
Publicado: (2023)

Prevalence of familial hypercholesterolemia and its association with coronary artery disease: A Chinese cohort study
por: Aihaiti, Xiapikatijiang, et al.
Publicado: (2023)

Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography
por: Lee, Wen-Jane, et al.
Publicado: (2021)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease
por: Pirazzi, Carlo, et al.
Publicado: (2019)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
por: Barrios, Vivencio, et al.
Publicado: (2022)

Genes Potentially Associated with Familial Hypercholesterolemia
por: Mikhailova, Svetlana, et al.
Publicado: (2019)

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease
por: Tada, Hayato, et al.
Publicado: (2018)

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review
por: Hovland, Anders, et al.
Publicado: (2022)

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
por: Ferrières, Jean, et al.
Publicado: (2022)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Primary coronary artery pseudoaneurysm in a patient with familial hypercholesterolemia
por: Fujiyoshi, Toshiki, et al.
Publicado: (2019)

Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
por: Vuorio, Alpo, et al.
Publicado: (2021)

Advancing Prediction of Pathogenicity of Familial Hypercholesterolemia LDL Receptor Commonest Variants With Machine Learning Models
por: Santos, Raul D.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gnofudkf206i17e54f1m67fiu2